Evaluation of Clinical Decisions and Assessment of Those at Risk of Primary Angle Closure by Community Optometrists
1 other identifier
observational
163
1 country
1
Brief Summary
Increases in the aging population has resulted in increased demand for glaucoma services. Glaucoma is a disease that if untreated, can lead to blindness. This increase and need for long term treatment with monitoring have resulted in a significant demand in the hospital eye service (HES). Many departments are now facing a considerable backlog of outpatient appointments and it's essential that these appointments are reserved for patients who are at risk of glaucoma blindness. Primary angle closure (PAC) glaucoma is a type of glaucoma, where the drainage route for the fluid inside the eye (known as the angle) is narrowed or blocked. It has been recently identified that approximately half of patients referred into the HES for a suspect narrow angle for further investigation are healthy and are immediately discharged. The exact reasons for these findings are unknown. This project will investigate clinical decisions by community optometrists who account for the majority of PAC referrals into the HES, as well as assessing their ability to evaluate those at risk of PAC. This project will also examine whether clinical agreement could be improved by providing an educational package. A clinical image database of angles will be acquired from glaucoma patients attending Moorfields Eye Hospital. A learning package discussing angle closure referral will also be developed. Community optometrists will be invited to complete a questionnaire on their clinical decision making. This will be followed by the vignette assessment, learning package and re-assessment. If this educational package and/or any other identifiers are found to improve agreement levels, this could reduce the number of referrals and enable community monitoring of those at low risk of developing PAC glaucoma in their lifetime.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2022
CompletedFirst Posted
Study publicly available on registry
September 16, 2022
CompletedStudy Start
First participant enrolled
December 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2024
CompletedFebruary 23, 2024
December 1, 2023
1.2 years
September 13, 2022
February 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Agreement of community optometrists on measuring Limbal anterior chamber depth
Levels of agreement and precision of optometrist observers before and after intervention of online educational package in assessment of Limbal anterior chamber depth as a surrogate measure of angle width. Agreement will be measured via an online assessment vignette assessment package. Weighted Kappa statistic and levels agreement will be the outcome measures
12 months
Secondary Outcomes (2)
Qualitative outcome measures from optometrists
12 months
Qualitative outcome measures from patients
12 months
Study Arms (2)
Patients
100 patient participants will be recruited for limbal anterior chamber depth image capture. These images will be used to develop the clinical vignette database
Optometrists
50 optometrists will be recruited to undertake the clinical vignette assessment
Interventions
Online learning package that will discuss the van Herick technique, grading, accuracy and information and discusses the current guidelines for primary angle closure suspect referral.
Eligibility Criteria
New patients to the glaucoma service will be selected as they would be a real-world reflection of those who have been identified at risk of developing glaucoma that have been referred for glaucoma investigation within the hospital eye service from primary care. Furthermore, they would have an enriched sample of narrow angles that are required to achieve the desired the case-mix required for the image database within the set timelines.
You may qualify if:
- New patients attending the glaucoma clinic at Moorfields Eye Hospital
You may not qualify if:
- They cannot be examined using a table mounted slit lamp due to physical limitations or have gross nystagmus.
- Unable to consent
- If they are unable to communicate in English and there is no available interpreter that meets requirements set out by Moorfields standard operating policies for patients
- Under 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moorfields Eye Hospital NHS Foundation Trust, 162 City Road
London, EC1V 2PD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anish Jindal
Moorfields Eye Hospital NHS Foundation Trust/UCL
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2022
First Posted
September 16, 2022
Study Start
December 7, 2022
Primary Completion
March 7, 2024
Study Completion
March 7, 2024
Last Updated
February 23, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share